Kindly note the the following Sessions/Presentations are NOT CME/CE Accredited:
- Febrile Neutropenia - New Concepts in the Use of Granulocyte Stimulating Factors - Friday, June 29 - 10:00-11:30 - Session not accredited
- Parallel Session - Antiemetics 1 - Report on the Nausea Workshop and Related Issues - ROLAPITANT, A NOVEL NK-1 RECEPTOR ANTAGONIST, FOR THE PREVENTION OF NAUSEA IN SUBJECTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC), D. Chua, A. Poma, M.L. Hedley, Hong Kong S.A.R., USA - Presentation not accredited due to conflict of interest
-
Oral Presentations - Proffered Papers I - Febrile Neutropenia- A RANDOMIZED, NON-INFERIORITY STUDY OF BALUGRASTIM AND PEGFILGRASTIM IN BREAST CANCER PATIENTS RECEIVING MYELOSUPPRESSIVE THERAPY , O. Gladkov, V. Moiseyenko, I.N. Bondarenko, Y. Shparyk, S. Barash, J.M. Herpst, U. Mueller, Russia, Ukraine, USA, German - Presentation not accredited due to conflict of interest
-
Oral Presentations - Proffered Papers I - Febrile Neutropenia- EFFICACY AND SAFETY OF BALUGRASTIM COMPARED WITH PEGFILGRASTIM IN PATIENTS WITH BREAST CANCER WHO ARE RECEIVING CHEMOTHERAPY, C. Volovat, O.A. Gladkov, I.M. Bondarenko, S. Barash, A. Buchner, N. Avisar, P. Bias, U. Mueller, Romania, Russia, Ukraine, USA, Germany, Israel - Presentation not accredited due to conflict of interest
-
Oral Presentations - Proffered Papers I - Febrile Neutropenia- A RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROL, MULTICENTER, DOSE FINDING STUDY OF LIPEGFILGRASTIM IN BREAST CANCER PATIENTS RECEIVING MYELOSUPPRESSIVE THERAPY, A. Buchner, P. Bias, M. Kaufmann, U. Mueller, Germany - Presentation not accredited due to conflict of interest
-
Plenary Session –Emerging and Under-Addressed Issues in Supportive Care - MOLECULAR PREDICTORS IN SUPPORTIVE CARE, S.Sonis, USA - Presentation not accredited due to conflict of interest
-
Parallel Session - Antiemetics 2 – New Agents and New Studies - AN EVALUATION OF THE DEGREE OF NEUROKININ-1 RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER NETUPITANT SINGLE DOSES ADMINISTRATION, G. Rossi, S. Olivari Tilola, C. Rudengren, M. Palmas, Switzerland, Sweden - Presentation not accredited due to conflict of interest
-
Parallel Session - Antiemetics 2 – New Agents and New Studies - EFFICACY AND SAFETY OF ROLAPITANT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SUBJECTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY, D. Chua, A. Poma, M.L. Hedley, Hong Kong S.A.R., USA - Presentation not accredited due to conflict of interest
-
Proffered Papers II - Assessment and Perceptions in Supportive Care – COST OF SKELETAL COMPLICATIONS FROM BONE METASTASES (BM): RESULTS FROM A RETROSPECTIVE EUROPEAN STUDY, O. Gunther, J.-J. Body, H. Sleeboom, G. Hechmati, J. Pereira, N. Maniadakis, E. Terpos, Y.-P. Acklin, J. Finek, R. von Moos, UK, Belgium, The Netherlands, Switzerland, Portugal, Greece, Czech Republic - Presentation not accredited due to conflict of interest
-
Proffered Papers IV - Oral, Cutaneous, Fatigue and Cachexia Issues – EFFECT OF ENOBOSARM ON PHYSICAL FUNCTION IN CANCER PATIENTS WITH < OR ≥5% WEIGHT LOSS IN A PHASE IIB TRIAL, S.T. Dodson, M.A. Johnston, M.L. Hancock, M.S. Steiner, J. Dalton, USA - Presentation not accredited due to conflict of interest
-
Proffered Papers IV - Oral, Cutaneous, Fatigue and Cachexia Issues – PREVALENCE AND IMPACT OF HYPOGONADISM IN CANCER PATIENTS WITH MUSCLE WASTING IN A PHASE IIB ENOBOSARM TRIAL, S.T. Dodson, A. Dobs, M.A. Johnston, M.L. Hancock, R.A. Morton, M.S. Steiner, J. Dalton, USA - Presentation not accredited due to conflict of interest
|